This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife.com.au has made no revisions to our, or Healthylife.com.au’s, product prescribe information available on the Uganda Drug Information Exchange. Please read the linked materials carefully before taking this medication.Healthylife.com.au has made no revisions to, contact the manufacturer, bazaarvoice.pk. Instead, Healthylife.com.au has placed this information at the head of the product’s sale announcement, please contact us via email ( [email protected] or message us at [email protected] you have any questions about this product, please contact Healthylife at either of the following addresses: bazaarvoice.pk: 9888445; bazaarvoice.pk: 9888446.Strattera Atomoxetine (60mg) is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It belongs to a class of drugs called selective norepinephrine reuptake inhibitors and works by inhibiting the reuptake of norepinephrine in the brain. This helps to increase alertness and alertness in individuals with ADHD.
Strattera Atomoxetine (60mg) is also used to treat adults with ADHD who do not respond to typical stimulant medications like Adderall or Ritalin. Strattera Atomoxetine (60mg) is prescribed for adults with ADHD who do not respond to stimulants like Ritalin or Adderall. Strattera Atomoxetine (60mg) should be taken at the same time every day with or without food. It is important to complete the full course of Strattera Atomoxetine (60mg) as prescribed by your healthcare provider.
Strattera Atomoxetine (60mg) may take several weeks to start working, depending on your response to the medication and the severity of your symptoms. If Strattera Atomoxetine (60mg) does not work as expected, your healthcare provider may gradually increase the dosage or recommend alternative treatments.
Strattera Atomoxetine (60mg) may be taken with or without food.
Strattera Atomoxetine (60mg) contains the active ingredient atomoxetine. This medication belongs to a class of drugs called norepinephrine reuptake inhibitors. Norepinephrine is a hormone that plays a role in regulating attention, impulse control, and behavior in humans and animals.
Strattera Atomoxetine (60mg) works by increasing the levels of norepinephrine in the brain, which helps to improve focus, attention, and the ability to stay awake. This increase in norepinephrine can assist in improving attention and impulse control.
Strattera Atomoxetine (60mg) is also used to treat adults with ADHD who do not respond to stimulant medications like Adderall or Ritalin. Strattera Atomoxetine (60mg) is also prescribed for adults with ADHD who do not respond to stimulant medications like Ritalin or Adderall.
Atomoxetine HCL, commonly known by its brand name Strattera, is a non-stimulant medication used to treat Attention-Deficit Hyperactivity Disorder (ADHD). It works by increasing the levels of norepinephrine in the brain, which helps improve attention, focus, and impulse control[2].
The global Atomoxetine HCL market is experiencing significant growth, driven by several key factors:
Several factors are driving the growth of the Atomoxetine HCL market:
The global Atomoxetine HCL market is segmented based on several criteria:
The market is highly competitive, with several major players:
In today's digital age, the first thing you should know about a medication is that it's available in generic forms. In our world, generics are the most common category of medications. The generic version of Strattera has been widely used since the late 1980s. It has been approved by the FDA since 2003 and has been marketed by several generic drug manufacturers.
There are several generic Strattera alternatives, but the most common ones are the generic versions manufactured by the American pharmaceutical company, Novartis (marketed as Strattera).
The generic form of Strattera, atomoxetine, also known as Tatom and sold under the brand name atomoxetine, has been the first approved by the FDA for the treatment of Attention-Deficit/Hyperactivity Disorder. This drug was originally developed by Eli Lilly. Eli Lilly was acquired by the company in 2010. The generic version of Strattera is marketed by GlaxoSmithKline (marketed as Strattera), which is a brand name for the generic drug, atomoxetine. Strattera is a non-stimulant medication.
The generic atomoxetine is available as a liquid tablet in tablet form. It's usually taken by mouth. It's a short-acting medication with a long-term effect that can last up to two years. The most common side effects are dry mouth, upset stomach, dizziness, constipation, and insomnia. These are usually mild and go away when the medication is stopped. The drug is usually well-tolerated by the body, so the generic version of atomoxetine is the only option.
In terms of effectiveness and safety, the generic atomoxetine is a relatively safe drug compared to the brand name version. The drug is approved by the FDA for the treatment of Attention-Deficit/Hyperactivity Disorder in adults and children. It is also approved for use in adults over the age of 12 and children below the age of 12. It is generally safe and well-tolerated by children.
While atomoxetine is effective in treating Attention-Deficit/Hyperactivity Disorder, the generic form is not the only option. Generic drugs are also used to treat ADHD as well. These drugs include both the brand name and generic forms. Generic drugs are often less expensive than the brand name version of Strattera.
While these generic drugs are not as effective as the brand name version, they can be a bit expensive. The average price for a 30-day supply of a generic version of Strattera is $300, while the brand-name version costs $1,600. However, some online pharmacies offer prices much lower than the brand-name version. This is because the brand name version is an over-the-counter medication, whereas the generic version is sold by a brand name.
In the past, generic drugs have been very expensive. The only way to ensure that the medication you are taking is the original medication is to buy the brand name medication at a very low price.
Strattera (atomoxetine) is a medication primarily used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults. It works by increasing the levels of norepinephrine in the brain, which helps improve attention and impulse control. Strattera, a medication primarily used to treat attention deficit hyperactivity disorder (ADHD), comes in a variety of dosage forms, such as tablet, capsule, and oral suspension. This article explores the uses, side effects, dosage, and dosage forms of Strattera, including the dosage and strength, side effects, and drug interactions.
| Brand Name | Generic Name | Strength |
| Strattera | 40 mg | 10 mg |
| Strattera Capsules | 20 mg | |
| Strattera Oral Suspension | 30 mg | |
| Strattera Tablets | 60 mg | |
| Strattera Oral Capsules | ||
| Strattera Oral Jelly | 50 mg | |
| Strattera Tablet Capsules | ||
The mechanism by which Strattera works is primarily through its ability to inhibit norepinephrine reuptake. This helps increase norepinephrine levels in the brain, which is responsible for attention and impulsivity.
In children, Strattera can lead to more pronounced ADHD symptoms, such as hyperactivity and impulsivity, compared to adults. This can cause increased impulsivity and hyperactivity in the brain, making it challenging to manage. It is essential to follow the dosage guidelines provided by your healthcare provider, including the recommended dosages and the strength of the medication. It is essential to maintain open communication with your healthcare provider to discuss any concerns or questions regarding Strattera usage.
It is important to note that Strattera dosage may vary depending on the child's age, weight, and other medications being taken. Your healthcare provider will be able to determine the most appropriate Strattera dosage based on your child's age, weight, and other factors. It is also important to consult with your healthcare provider before starting any new medication to ensure safety and efficacy.
Strattera can cause side effects, although not everyone experiences them. Some common side effects include:
If you experience any side effects that persist or worsen, talk to your healthcare provider. They can provide personalized advice and monitor your progress to ensure your well-being.
To view the full list of side effects and discuss any concerns with your healthcare provider:
Stade de France Pharmacy